Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda

James Ayieko, Maya L Petersen, Jane Kabami, Florence Mwangwa, Fred Opel, Marilyn Nyabuti, Edwin D Charlebois, James Peng, Catherine A Koss, Laura B Balzer, Gabriel Chamie, Elizabeth A Bukusi, Moses R Kamya, Diane V Havlir, James Ayieko, Maya L Petersen, Jane Kabami, Florence Mwangwa, Fred Opel, Marilyn Nyabuti, Edwin D Charlebois, James Peng, Catherine A Koss, Laura B Balzer, Gabriel Chamie, Elizabeth A Bukusi, Moses R Kamya, Diane V Havlir

Abstract

Introduction: Antiretroviral-based HIV prevention, including pre-exposure prophylaxis (PrEP), is expanding in generalized epidemic settings, but additional prevention options are needed for individuals with periodic, high-risk sexual exposures. Non-occupational post-exposure prophylaxis (PEP) is recommended in global guidelines. However, in Africa, awareness of and access to PEP for sexual exposures are limited. We assessed feasibility, acceptability, uptake and adherence in a pilot study of a patient-centred PEP programme with options for facility- or community-based service delivery.

Methods: After population-level HIV testing with universal access to PrEP for persons at elevated HIV risk (SEARCH Trial:NCT01864603), we conducted a pilot PEP study in five rural communities in Kenya and Uganda between December 2018 and May 2019. We assessed barriers to PEP in the population and implemented an intervention to address these barriers, building on existing in-country PEP protocols. We used community leaders for sensitization. Test kits and medications were acquired through the Ministry of Health supply chain and healthcare providers based at the Ministry of Health clinics were trained on PEP delivery. Additional intervention components were (a)PEP availability seven days/week, (b)PEP hotline staffed by providers and (c)option for out-of-facility medication delivery. We assessed implementation using the Proctor framework and measured seroconversions via repeat HIV testing. Successful "PEP completion" was defined as self-reported adherence over four weeks of therapy with post-PEP HIV testing.

Results: Community leaders were able to sensitize and mobilize for PEP. The Ministry of Health supplied test kits and PEP medications; after training, healthcare providers delivered the 28-day regimen with high completion rates. Among 124 persons who sought PEP, 66% were female, 24% were ≤25 years and 42% were fisherfolk. Of these, 20% reported exposure with a serodifferent partner, 72% with a new or existing relationship and 7% from transactional sex. 12% of all visits were conducted at out-of-facility community-based sites; 35% of participants had ≥1 out-of-facility visit. No serious adverse events were reported. Overall, 85% met the definition of PEP completion. There were no HIV seroconversions.

Conclusions: Among individuals with elevated-risk exposures in rural East African communities, patient-centred PEP was feasible, acceptable and provides a promising addition to the current prevention toolkit.

Keywords: HIV prevention; high-risk exposure; implementation; post-exposure prophylaxis (PEP); pre-exposure prophylaxis (PrEP); uptake.

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Figures

Figure 1
Figure 1
PEP retention, adherence and HIV testing during the course of the pilot. (Retention: Visit attendance at week 1, 2 and 4, Adherence: Use of PrEP measured by self‐report using three‐day recall, HIV Tested: Proportion receiving a HIV test at specified week 4 study visit).

References

    1. Ford N, Mayer KH, Barlow L, Bagyinszky F, Calmy A, Chakroun M, et al. World Health Organization guidelines on postexposure prophylaxis for hiv: recommendations for a public health approach. Clin Infect Dis. 2015;60 suppl_3:S161–4.
    1. World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, Second edition [Internet] [cited 2020 Jul 24]. 2016.
    1. Siika AM, Nyandiko WM, Mwangi A, Waxman M, Sidle JE, Kimaiyo SN, et al. The structure and outcomes of a HIV postexposure prophylaxis program in a high HIV prevalence setup in western Kenya. J Acquir Immune Defic Syndr. 2009;51(1):47–53.
    1. Izulla P, McKinnon LR, Munyao J, Karanja S, Koima W, Parmeres J, et al. HIV postexposure prophylaxis in an urban population of female sex workers in Nairobi, Kenya. JAIDS J Acquir Immune Defic Syndr. 2013;62(2):220–5.
    1. Restar AJ, Tocco JU, Mantell JE, Lafort Y, Gichangi P, Masvawure TB, et al. Perspectives on HIV pre‐ and post‐exposure prophylaxes (PrEP and PEP) among female and male sex workers in Mombasa, Kenya: implications for integrating biomedical prevention into sexual health services. AIDS Educ Prev. 2017;29(2):141–53.
    1. Scorgie F, Nakato D, Harper E, Richter M, Maseko S, Nare P, et al. 'We are despised in the hospitals': sex workers' experiences of accessing health care in four African countries. Cult Health Sex. 2013;15(4):450–65.
    1. Isano S, Wong R, Logan J, El‐Halabi S, El‐Khatib Z. Barriers to post exposure prophylaxis use among men who have sex with men in sub‐Saharan Africa: An online cross‐sectional survey. Prev Med Rep. 2020;28:101100.
    1. Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, et al. Early adopters of human immunodeficiency virus preexposure prophylaxis in a population‐based combination prevention study in rural Kenya and Uganda. Clin Infect Dis. 2018;67(12):1853–60.
    1. Ahmed N, Pike C, Bekker LG. Scaling up pre‐exposure prophylaxis in sub‐Saharan Africa. Curr Opin Infect Dis. 2019;32(1):24–30.
    1. Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, et al. Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan Africa. J Int AIDS Soc. 2018;21:e25048
    1. Zheng W, Balzer L, van der Laan M, Petersen M, Collaboration SEARCH. Constrained binary classification using ensemble learning: an application to cost‐efficient targeted PrEP strategies. Stat Med. 2018;37(2):261–79.
    1. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, et al. Uptake, engagement, and adherence to pre‐exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72‐week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;7(4):e249–61.
    1. Ministry of Health, National AIDS & STI Control Programme Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya 2016. Nairobi, Kenya: NASCOP; 2016.
    1. Consolidated Guidelines for prevention and treatment of HIV in Uganda. Kampala: MoH; 2016. [cited 2019 Feb 21] Available from:
    1. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
    1. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS . Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Corrected Version 2.1. [July 2017]. [cited 2020 Jul 14] Available from:
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
    1. Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24(7):2149–62.
    1. Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, et al. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019;22:e25276.
    1. Rabin BA, Brownson RC, Haire‐Joshu D, Kreuter MW, Weaver NL. A glossary for dissemination and implementation research in health. J Public Health Manag Pract. 2008;14(2):117–123.

Source: PubMed

3
Subskrybuj